Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

News Daily News

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Michael O'Riordan

December 27, 2023

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Daily News

Outcomes Suffer When Device-Related Thrombus Persists or Recurs After LAAO

Todd Neale

November 29, 2023

News Daily News

PCI With Intravascular Imaging or Functional Testing Bests Angiography Alone

Michael O'Riordan

November 24, 2023

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HCM3

News Conference News AHA 2023

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

Shelley Wood

November 11, 2023

News Daily News

Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’

Yael L. Maxwell

November 08, 2023

News Conference News TCT 2023

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Yael L. Maxwell

November 06, 2023

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

L.A. McKeown

October 31, 2023

News Conference News TCT 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Caitlin E. Cox

October 27, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Conference News TCT 2023

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Caitlin E. Cox

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

News Daily News

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

Yael L. Maxwell

October 09, 2023

News Conference News ESC 2023

MULTISTARS AMI: Immediate Complete PCI in STEMI as Safe as Staged Revascularization

Michael O'Riordan

August 28, 2023

News Conference News ESC 2023

Four Intravascular Imaging Studies Shared the ESC Spotlight, Yet Shadows Persist

Shelley Wood

August 27, 2023

News Conference News ESC 2023

STOPDAPT-3: Don’t Skip Out on Aspirin Immediately After PCI

Todd Neale

August 26, 2023

News Conference News SCAI 2023

SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year

L.A. McKeown

May 31, 2023

News Conference News SCAI 2023

Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis

L.A. McKeown

May 30, 2023

Advertisement

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Top Coronary Artery Disease News of 2023

Outcomes Suffer When Device-Related Thrombus Persists or Recurs After LAAO

PCI With Intravascular Imaging or Functional Testing Bests Angiography Alone

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Comparing DCBs in De Novo CAD: Drugs, Design Matter

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

MULTISTARS AMI: Immediate Complete PCI in STEMI as Safe as Staged Revascularization

Four Intravascular Imaging Studies Shared the ESC Spotlight, Yet Shadows Persist

STOPDAPT-3: Don’t Skip Out on Aspirin Immediately After PCI

SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year

Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content